Nonremission and time to remission among remitters in major depressive disorder: Revisiting STAR*D

Depression and Anxiety

Volumn 34, Issue 12, 2017, Pages 1123-1133

  Mojtabai, Ramin ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

antidepressant agents; depression; major depressive disorder; treatment outcomes; treatment resistant depressive disorder

Indexed keywords

ADULT; ARTICLE; DISEASE SEVERITY; EDUCATIONAL STATUS; ETHNICITY; FEMALE; FUNCTIONAL ASSESSMENT; HEALTH STATUS; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MARRIAGE; MENTAL HEALTH; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; REMISSION; SCORING SYSTEM; UNEMPLOYMENT; ADOLESCENT; AGED; CLINICAL TRIAL; MIDDLE AGED; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); REMISSION INDUCTION; YOUNG ADULT;

EID: 85027517688     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22677     Document Type: Article

References (67)

1. Akincigil, A., Bowblis, J. R., Levin, C., Walkup, J. T., Jan, S., & Crystal, S. (2007). Adherence to antidepressant treatment among privately insured patients diagnosed with depression. Medical Care, 45(4), 363–369. https://doi.org/10.1097/01.mlr.0000254574.23418.f6
2. American Psychiatric Association. (2010). Practice guideline for the treatment of patients with major depressive disorder (3rd ed.). Washington, DC: American Psychiatric Association.
3. American Psychiatric Association & American Psychiatric Association, DSM-5 Task Force. (2013). Diagnostic and statistical manual of mental disorders: DSM-5 (5th ed.). Washington, DC: American Psychiatric Association.
4. Anttila, S., Kampman, O., Illi, A., Rontu, R., Lehtimaki, T., & Leinonen, E. (2007). Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics: A serotonergic approach. BMC Psychiatry, 7, 22. https://doi.org/10.1186/1471-244X-7-22
5. Arnow, B. A., Blasey, C., Williams, L. M., Palmer, D. M., Rekshan, W., Schatzberg, A. F., … Rush, A. J. (2015). Depression subtypes in predicting antidepressant response: A report from the iSPOT-D Trial. American Journal of Psychiatry, 172(8), 743–750. https://doi.org/10.1176/appi.ajp.2015.14020181
6. Bennabi, D., Aouizerate, B., El-Hage, W., Doumy, O., Moliere, F., Courtet, P., … Haffen, E. (2015). Risk factors for treatment resistance in unipolar depression: A systematic review. Journal of Affective Disorders, 171, 137–141. https://doi.org/10.1016/j.jad.2014.09.020
7. Berkson, J., & Gage, R. P. (1952). Survival curve for cancer patients following treatment. Journal of the American Statistical Association, 47(259), 501–515.
8. Berlim, M. T., & Turecki, G. (2007a). Definition, assessment, and staging of treatment-resistant refractory major depression: A review of current concepts and methods. Canadian Journal of Psychiatry, 52(1), 46–54. https://doi.org/10.1177/070674370705200108
9. Berlim, M. T., & Turecki, G. (2007b). What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials. European Neuropsychopharmacology, 17(11), 696–707. https://doi.org/10.1016/j.euroneuro.2007.03.009
10. Blanco, C., Okuda, M., Markowitz, J. C., Liu, S. M., Grant, B. F., & Hasin, D. S. (2010). The epidemiology of chronic major depressive disorder and dysthymic disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 71(12), 1645–1656. https://doi.org/10.4088/JCP.09m05663gry
11. Boschloo, L., Schoevers, R. A., Beekman, A. T., Smit, J. H., van Hemert, A. M., & Penninx, B. W. (2014). The four-year course of major depressive disorder: The role of staging and risk factor determination. Psychotherapy and Psychosomatics, 83(5), 279–288. https://doi.org/10.1159/000362563
12. Cheng, I. C., Liao, S. C., Lee, M. B., & Tseng, M. M. (2007). Predictors of treatment response and length of stay for inpatients with major depression. Journal of the Formosan Medical Association, 106(11), 903–910. https://doi.org/10.1016/S0929-6646(08)60060-60061
13. Cleves, M. A. (2010). An introduction to survival analysis using Stata (3rd ed.). College Station, TX: Stata Press.
14. Cook, I. A., Leuchter, A. F., Witte, E., Abrams, M., Uijtdehaage, S. H., Stubbeman, W., … Dunkin, J. J. (1999). Neurophysiologic predictors of treatment response to fluoxetine in major depression. Psychiatry Research, 85(3), 263–273.
15. Fava, M., Alpert, J. E., Carmin, C. N., Wisniewski, S. R., Trivedi, M. H., Biggs, M. M., … Rush, A. J. (2004). Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychological Medicine, 34(7), 1299–1308.
16. Fava, M., Rush, A. J., Alpert, J. E., Balasubramani, G. K., Wisniewski, S. R., Carmin, C. N., … Trivedi, M. H. (2008). Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report. American Journal of Psychiatry, 165(3), 342–351. https://doi.org/10.1176/appi.ajp.2007.06111868
17. Gaynes, B. (2009). Identifying difficult-to-treat depression: Differential diagnosis, subtypes, and comorbidities. Journal of Clinical Psychiatry, 6(70 Suppl), 10–15. https://doi.org/10.4088/JCP.8133su1c.02
18. Gaynes, B. (2016). Assessing the risk factors for difficult-to-treat depression and treatment-resistant depression. Journal of Clinical Psychiatry, 1(77 Suppl), 4–8. https://doi.org/10.4088/JCP.14077su1c.01
19. Greenblatt, M., Grosser, G. H., & Wechsler, H. (1964). Differential response of hospitalized depressed patients to somatic therapy. American Journal of Psychiatry, 120, 935–943. https://doi.org/10.1176/ajp.120.10.935
20. Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56–62.
21. Joel, I., Begley, A. E., Mulsant, B. H., Lenze, E. J., Mazumdar, S., & Dew, M. A., … Irl Grey Investigative Team. (2014). Dynamic prediction of treatment response in late-life depression. American Journal of Geriatric Psychiatry, 22(2), 167–176. https://doi.org/10.1016/j.jagp.2012.07.002
22. Joyce, P. R., & Paykel, E. S. (1989). Predictors of drug response in depression. Archives of Gen Psychiatry, 46(1), 89–99.
23. Katon, W., Von Korff, M., Lin, E., Simon, G., Walker, E., Unutzer, J., … Ludman, E. (1999). Stepped collaborative care for primary care patients with persistent symptoms of depression: A randomized trial. Arch General Psychiatry, 56(12), 1109–1115.
24. Keller, M. B., Gelenberg, A. J., Hirschfeld, R. M., Rush, A. J., Thase, M. E., Kocsis, J. H., … Harrison, W. M. (1998). The treatment of chronic depression. Part 2: A double-blind, randomized trial of sertraline and imipramine. Journal of Clinical Psychiatry, 59(11), 598–607.
25. Khan, A. Y., Carrithers, J., Preskorn, S. H., Lear, R., Wisniewski, S. R., John Rush, A., … Fava, M. (2006). Clinical and demographic factors associated with DSM-IV melancholic depression. Annals of Clinical Psychiatry, 18(2), 91–98. https://doi.org/10.1080/10401230600614496
26. Kiloh, L. G., Ball, J. R., & Garside, R. F. (1962). Prognostic factors in treatment of depressive states with imipramine. British Medical Journal, 1(5287), 1225–1227.
27. Klein, D. N., Arnow, B. A., Barkin, J. L., Dowling, F., Kocsis, J. H., Leon, A. C., … Wisniewski, S. R. (2009). Early adversity in chronic depression: Clinical correlates and response to pharmacotherapy. Depression and Anxiety, 26(8), 701–710. https://doi.org/10.1002/da.20577
28. Kuk, A. Y., Li, J., & Rush, A. J. (2010). Recursive subsetting to identify patients in the STAR*D: A method to enhance the accuracy of early prediction of treatment outcome and to inform personalized care. Journal of Clinical Psychiatry, 71(11), 1502–1508. https://doi.org/10.4088/JCP.10m06168blu
29. Lambert, P. C., Thompson, J. R., Weston, C. L., & Dickman, P. W. (2007). Estimating and modeling the cure fraction in population-based cancer survival analysis. Biostatistics, 8(3), 576–594. https://doi.org/10.1093/biostatistics/kxl030
30. Linn, B. S., Linn, M. W., & Gurel, L. (1968). Cumulative illness rating scale. Journal of American Geriatric Society, 16(5), 622–626.
31. Luo, Z., Cowell, A. J., Musuda, Y. J., Novak, S. P., & Johnson, E. O. (2010). Course of major depressive disorder and labor market outcome disruption. Journal of Mental Health Policy and Economics, 13(3), 135–149.
32. Maller, R. A., & Zhou, X. (1996). Survival analysis with long-term survivors. Chichester, NY: Wiley.
33. McGrath, P. J., Khan, A. Y., Trivedi, M. H., Stewart, J. W., Morris, D. W., Wisniewski, S. R., … Rush, A. J. (2008). Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: A STAR*D report. Journal of Clinical Psychiatry, 69(12), 1847–1855.
34. Miller, M. D., Paradis, C. F., Houck, P. R., Mazumdar, S., Stack, J. A., Rifai, A. H., … Reynolds, C. F., 3rd. (1992). Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale. Psychiatry Res, 41(3), 237–248.
35. Mojtabai, R., & Olfson, M. (2008). National patterns in antidepressant treatment by psychiatrists and general medical providers: Results from the national comorbidity survey replication. Journal of Clinical Psychiatry, 69(7), 1064–1074.
36. Mojtabai, R., Rosenheck, R. A., Wyatt, R. J., & Susser, E. S. (2003). Use of VA aftercare following military discharge among patients with serious mental disorders. Psychiatric Services, 54(3), 383–388. https://doi.org/10.1176/appi.ps.54.3.383
37. Mojtabai, R., Stuart, E. A., Hwang, I., Eaton, W. W., Sampson, N., & Kessler, R. C. (2015). Long-term effects of mental disorders on educational attainment in the National Comorbidity Survey ten-year follow-up. Social Psychiatry and Psychiatric Epidemiology, 50(10), 1577–1591. https://doi.org/10.1007/s00127-015-1083-5
38. Mojtabai, R., Stuart, E. A., Hwang, I., Susukida, R., Eaton, W. W., Sampson, N., & Kessler, R. C. (2015). Long-term effects of mental disorders on employment in the National Comorbidity Survey ten-year follow-up. Social Psychiatry and Psychiatric Epidemiology, 50(11), 1657–1668. https://doi.org/10.1007/s00127-015-1097-z
39. Mundt, J. C., Marks, I. M., Shear, M. K., & Greist, J. H. (2002). The Work and Social Adjustment Scale: A simple measure of impairment in functioning. British Journal of Psychiatry, 180, 461–464.
40. Muthen, B., Asparouhov, T., Hunter, A. M., & Leuchter, A. F. (2011). Growth modeling with nonignorable dropout: Alternative analyses of the STAR*D antidepressant trial. Psychological Methods, 16(1), 17–33. https://doi.org/10.1037/a0022634
41. Novick, J. S., Stewart, J. W., Wisniewski, S. R., Cook, I. A., Manev, R., & Nierenberg, A. A., … STAR*D investigators. (2005). Clinical and demographic features of atypical depression in outpatients with major depressive disorder: Preliminary findings from STAR*D. Journal of Clinical Psychiatry, 66(8), 1002–1011.
42. Paykel, E. S., Hollyman, J. A., Freeling, P., & Sedgwick, P. (1988). Predictors of therapeutic benefit from amitriptyline in mild depression: A general practice placebo-controlled trial. Journal of Affective Disorders, 14(1), 83–95.
43. Perlis, R. H., Uher, R., Ostacher, M., Goldberg, J. F., Trivedi, M. H., Rush, A. J., & Fava, M. (2011). Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder. Archives of General Psychiatry, 68(4), 351–360.https://doi.org/10.1001/archgenpsychiatry.2010.179
44. Pizzagalli, D., Pascual-Marqui, R. D., Nitschke, J. B., Oakes, T. R., Larson, C. L., Abercrombie, H. C., … Davidson, R. J. (2001). Anterior cingulate activity as a predictor of degree of treatment response in major depression: Evidence from brain electrical tomography analysis. American Journal of Psychiatry, 158(3), 405–415. https://doi.org/10.1176/appi.ajp.158.3.405
45. Rasmussen, K. G., Mueller, M., Knapp, R. G., Husain, M. M., Rummans, T. A., Sampson, S. M., … Kellner, C. H. (2007). Antidepressant medication treatment failure does not predict lower remission with ECT for major depressive disorder: A report from the consortium for research in electroconvulsive therapy. Journal of Clinical Psychiatry, 68(11), 1701–1706.
46. Reilly, T. J., MacGillivray, S. A., Reid, I. C., & Cameron, I. M. (2015). Psychometric properties of the 16-item Quick Inventory of Depressive Symptomatology: A systematic review and meta-analysis. Journal of Psychiatric Research, 60, 132–140. https://doi.org/10.1016/j.jpsychires.2014.09.008
47. Rubio, J. M., Markowitz, J. C., Alegria, A., Perez-Fuentes, G., Liu, S. M., Lin, K. H., & Blanco, C. (2011). Epidemiology of chronic and nonchronic major depressive disorder: Results from the national epidemiologic survey on alcohol and related conditions. Depression and Anxiety, 28(8), 622–631. https://doi.org/10.1002/da.20864
48. Rush, A. J., Bernstein, I. H., Trivedi, M. H., Carmody, T. J., Wisniewski, S., Mundt, J. C., … Fava, M. (2006). An evaluation of the quick inventory of depressive symptomatology and the Hamilton rating scale for depression: A sequenced treatment alternatives to relieve depression trial report. Biological Psychiatry, 59(6), 493–501. https://doi.org/10.1016/j.biopsych.2005.08.022
49. Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., & Sackeim, H. A., … STAR*D Investigators Group. (2004). Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design. Controlled Clinical Trials, 25(1), 119–142.
50. Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., … Keller, M. B. (2003). The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biological Psychiatry, 54(5), 573–583.
51. Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., … Fava, M. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. American Journal of Psychiatry, 163(11), 1905–1917. https://doi.org/10.1176/ajp.2006.163.11.1905
52. Sackeim, H. A., Rush, A. J., George, M. S., Marangell, L. B., Husain, M. M., Nahas, Z., … Goodman, R. R. (2001). Vagus nerve stimulation (VNS) for treatment-resistant depression: Efficacy, side effects, and predictors of outcome. Neuropsychopharmacology, 25(5), 713–728. https://doi.org/10.1016/S0893-133X(01)00271-00278
53. Sherbourne, C., Schoenbaum, M., Wells, K. B., & Croghan, T. W. (2004). Characteristics, treatment patterns, and outcomes of persistent depression despite treatment in primary care. General Hospital Psychiatry, 26(2), 106–114. https://doi.org/10.1016/j.genhosppsych.2003.08.009
54. Sotsky, S. M., Glass, D. R., Shea, M. T., Pilkonis, P. A., Collins, J. F., Elkin, I., … Oliveri, M. E. (1991). Patient predictors of response to psychotherapy and pharmacotherapy: Findings in the NIMH Treatment of Depression Collaborative Research Program. American Journal of Psychiatry, 148(8), 997–1008. https://doi.org/10.1176/ajp.148.8.997
55. Souery, D., Oswald, P., Massat, I., Bailer, U., Bollen, J., & Demyttenaere, K., … Group for the Study of Resistant Depression. (2007). Clinical factors associated with treatment resistance in major depressive disorder: Results from a European multicenter study. Journal of Clinical Psychiatry, 68(7), 1062–1070.
56. Stulz, N., Thase, M. E., Klein, D. N., Manber, R., & Crits-Christoph, P. (2010). Differential effects of treatments for chronic depression: A latent growth model reanalysis. Journal of Consulting and Clinical Psychology, 78(3), 409–419. https://doi.org/10.1037/a0019267
57. Sung, S. C., Wisniewski, S. R., Balasubramani, G. K., Zisook, S., Kurian, B., & Warden, D., … Co-Med Study Team. (2013). Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report. Psychological Medicine, 43(5), 945–960. https://doi.org/10.1017/S0033291712001742
58. Trivedi, M. H., Rush, A. J., Ibrahim, H. M., Carmody, T. J., Biggs, M. M., Suppes, T., … Kashner, T. M. (2004). The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: A psychometric evaluation. Psychological Medicine, 34(1), 73–82.
59. Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., & Ritz, L., … STAR*D Study Team. (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. American Journal of Psychiatry, 163(1), 28–40. https://doi.org/10.1176/appi.ajp.163.1.28
60. Voltas, N., Hernandez-Martinez, C., Aparicio, E., Arija, V., & Canals, J. (2014). Psychopathological factors that can influence academic achievement in early adolescence: A three-year prospective study. Spanish Journal of Psychology, 17(E100). https://doi.org/10.1017/sjp.2014.100
61. Vuorilehto, M. S., Melartin, T. K., Riihimaki, K., & Isometsa, E. T. (2016). Pharmacological and psychosocial treatment of depression in primary care: Low intensity and poor adherence and continuity. Journal of Affective Disorders, 202, 145–152. https://doi.org/10.1016/j.jad.2016.05.035
62. Ware, J., Jr., Kosinski, M., & Keller, S. D. (1996). A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34(3), 220–233.
63. Wiersma, J. E., van Oppen, P., van Schaik, D. J., van der Does, A. J., Beekman, A. T., & Penninx, B. W. (2011). Psychological characteristics of chronic depression: A longitudinal cohort study. Journal of Clinical Psychiatry, 72(3), 288–294. https://doi.org/10.4088/JCP.09m05735blu
64. Young, A. S., Klap, R., Shoai, R., & Wells, K. B. (2008). Persistent depression and anxiety in the United States: Prevalence and quality of care. Psychiatric Services, 59(12), 1391–1398. https://doi.org/10.1176/appi.ps.59.12.1391
65. Zhang, C., Li, Z., Wu, Z., Chen, J., Wang, Z., Peng, D., … Fang, Y. (2014). A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression. Psychopharmacology (Berlin), 231(4), 685–693. https://doi.org/10.1007/s00213-013-3297-0
66. Zimmerman, M., & Mattia, J. I. (2001a). The Psychiatric Diagnostic Screening Questionnaire: Development, reliability and validity. Comprehensive Psychiatry, 42(3), 175–189. https://doi.org/10.1053/comp.2001.23126
67. Zimmerman, M., & Mattia, J. I. (2001b). A self-report scale to help make psychiatric diagnoses: The Psychiatric Diagnostic Screening Questionnaire. Archives of General Psychiatry, 58(8), 787–794.